Patents by Inventor Pradeep Kumar Kare
Pradeep Kumar Kare has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240139204Abstract: The present invention relates to stable injectable compositions comprising meloxicam or its pharmaceutically acceptable salts, solvates, or hydrates thereof, wherein the composition is provided in a sealed container, e.g., an ampoule, vial and pre-filled syringe. Further, the present invention relates to a stable injectable solution comprising meloxicam or its pharmaceutically acceptable salts, solvates, or hydrates thereof, suitable for subcutaneous, intravenous or intramuscular administration. The invention relates to methods for manufacturing stable injectable solutions of meloxicam. The present invention further relates to a method of treating pain by parenterally administering to a patient in need thereof a composition comprising a stable solution of meloxicam, wherein said solution provides rapid onset of action for pain relief compared to a reference composition.Type: ApplicationFiled: December 15, 2023Publication date: May 2, 2024Applicant: SLAYBACK PHARMA LLCInventors: Ashish Anilrao DUBEWAR, Sumitra Ashokkumar PILLAI, Pradeep Kumar KARE, Kumar Swamy UMMITI, Shanker MAMIDI, Raghavender Rao KATEGHER
-
Publication number: 20240108571Abstract: The present invention relates to injectable pharmaceutical compositions comprising therapeutically effective amount of succinylcholine chloride, one or more pharmaceutically acceptable aqueous solvents, and one or more stabilizing agents selected from aliphatic polyols; lower alkyl alcohols; amino acids having at least one additional amino, carboxyl or hydroxyl group; amino alcohols; and aliphatic dicarboxylic acids having at least one hydroxyl or amino group, or ?-? unsaturation. The compositions are stable at room temperature for at least 30 days. Methods of manufacturing the injectable pharmaceutical compositions are also provided. The composition may be provided in a sealed container, e.g., an ampoule, vial and pre-filled syringe, and are suitable for subcutaneous, intravenous or intramuscular administration as an adjunct to general anesthesia, to facilitate tracheal intubation, and/or to provide skeletal muscle relaxation during surgery or mechanical ventilation.Type: ApplicationFiled: December 4, 2023Publication date: April 4, 2024Applicant: Slayback Pharma LLC.Inventors: Ashish Anilrao Dubewar, Amit Anil Charkha, Sumitra Ashokkumar Pillai, Pradeep Kumar Kare, Kumar Swamy Ummiti, Shanker Mamidi, Mayur Anshiram Adhav
-
Patent number: 11872305Abstract: The present invention relates to injectable pharmaceutical compositions comprising therapeutically effective amount of succinylcholine chloride, one or more pharmaceutically acceptable aqueous solvents, and one or more stabilizing agents selected from aliphatic polyols; lower alkyl alcohols; amino acids having at least one additional amino, carboxyl or hydroxyl group; amino alcohols; and aliphatic dicarboxylic acids having at least one hydroxyl or amino group, or ?-? unsaturation. The compositions are stable at room temperature for at least 30 days. Methods of manufacturing the injectable pharmaceutical compositions are also provided. The composition may be provided in a sealed container, e.g., an ampoule, vial and pre-filled syringe, and are suitable for subcutaneous, intravenous or intramuscular administration as an adjunct to general anesthesia, to facilitate tracheal intubation, and/or to provide skeletal muscle relaxation during surgery or mechanical ventilation.Type: GrantFiled: August 26, 2022Date of Patent: January 16, 2024Inventors: Ashish Anilrao Dubewar, Amit Anil Charkha, Sumitra Ashokkumar Pillai, Pradeep Kumar Kare, Kumar Swamy Ummiti, Shanker Mamidi, Mayur Anshiram Adhav
-
Publication number: 20230086729Abstract: The present invention relates to injectable pharmaceutical compositions comprising therapeutically effective amount of succinylcholine chloride, one or more pharmaceutically acceptable aqueous solvents, and one or more stabilizing agents selected from aliphatic polyols; lower alkyl alcohols; amino acids having at least one additional amino, carboxyl or hydroxyl group; amino alcohols; and aliphatic dicarboxylic acids having at least one hydroxyl or amino group, or ?-? unsaturation. The compositions are stable at room temperature for at least 30 days. Methods of manufacturing the injectable pharmaceutical compositions are also provided. The composition may be provided in a sealed container, e.g., an ampoule, vial and pre-filled syringe, and are suitable for subcutaneous, intravenous or intramuscular administration as an adjunct to general anesthesia, to facilitate tracheal intubation, and/or to provide skeletal muscle relaxation during surgery or mechanical ventilation.Type: ApplicationFiled: August 25, 2022Publication date: March 23, 2023Applicant: Slayback Pharma LLCInventors: Ashish Anilrao Dubewar, Amit Anil Charkha, Sumitra Ashokkumar Pillai, Pradeep Kumar Kare, Kumar Swamy Ummiti, Shanker Mamidi, Mayur Anshtram Adhav
-
Publication number: 20230091021Abstract: The present invention relates to injectable pharmaceutical compositions comprising therapeutically effective amount of succinylcholine chloride, one or more pharmaceutically acceptable aqueous solvents, and one or more stabilizing agents selected from aliphatic polyols; lower alkyl alcohols; amino acids having at least one additional amino, carboxyl or hydroxyl group; amino alcohols; and aliphatic dicarboxylic acids having at least one hydroxyl or amino group, or ?-? unsaturation. The compositions are stable at room temperature for at least 30 days. Methods of manufacturing the injectable pharmaceutical compositions are also provided. The composition may be provided in a sealed container, e.g., an ampoule, vial and pre-filled syringe, and are suitable for subcutaneous, intravenous or intramuscular administration as an adjunct to general anesthesia, to facilitate tracheal intubation, and/or to provide skeletal muscle relaxation during surgery or mechanical ventilation.Type: ApplicationFiled: August 26, 2022Publication date: March 23, 2023Applicant: Slayback Pharma LLCInventors: Ashish Anilrao Dubewar, Amit Anil Charkha, Sumitra Ashokkumar Pillai, Pradeep Kumar Kare, Kumar Swamy Ummiti, Shanker Mamidi, Mayur Anshtram Adhav
-
Publication number: 20220249507Abstract: The present invention relates to stable injectable compositions comprising meloxicam or its pharmaceutically acceptable salts, solvates, or hydrates thereof, wherein the composition is provided in a sealed container, e.g., an ampoule, vial and pre-filled syringe. Further, the present invention relates to a stable injectable solution comprising meloxicam or its pharmaceutically acceptable salts, solvates, or hydrates thereof, suitable for subcutaneous, intravenous or intramuscular administration. The invention relates to methods for manufacturing stable injectable solutions of meloxicam. The present invention further relates to a method of treating pain by parenterally administering to a patient in need thereof a composition comprising a stable solution of meloxicam, wherein said solution provides rapid onset of action for pain relief compared to a reference composition.Type: ApplicationFiled: April 21, 2022Publication date: August 11, 2022Inventors: Ashish Anilrao DUBEWAR, Sumitra Ashokkumar PILLAI, Pradeep Kumar KARE, Kumar Swamy UMMITI, Shanker MAMIDI, Raghavender Rao KATEGHER
-
Publication number: 20220008337Abstract: The present invention relates to stable injectable compositions comprising meloxicam or its pharmaceutically acceptable salts, solvates, or hydrates thereof, wherein the composition is provided in a sealed container, e.g., an ampoule, vial and pre-filled syringe. Further, the present invention relates to a stable injectable solution comprising meloxicam or its pharmaceutically acceptable salts, solvates, or hydrates thereof, suitable for subcutaneous, intravenous or intramuscular administration. The invention relates to methods for manufacturing stable injectable solutions of meloxicam. The present invention further relates to a method of treating pain by parenterally administering to a patient in need thereof a composition comprising a stable solution of meloxicam, wherein said solution provides rapid onset of action for pain relief compared to a reference composition.Type: ApplicationFiled: July 6, 2021Publication date: January 13, 2022Inventors: Ashish Anilrao DUBEWAR, Sumitra Ashokkumar PILLAI, Pradeep Kumar KARE, Kumar Swamy UMMITI, Shanker MAMIDI, Raghavender Rao KATEGHER
-
Publication number: 20190262314Abstract: The present invention provides stable, ready-to-use pharmaceutical compositions, comprising dexmedetomidine or a pharmaceutically acceptable salt thereof, one or more pharmaceutically acceptable excipients, and a pharmaceutically acceptable liquid vehicle, where the composition is provided in a sealed container that comprises a cyclic olefin polymer. The present invention also provides ready-to-use pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof, a pharmaceutically acceptable liquid vehicle and an antioxidant and/or stabilizer, such as L-methionine. These solutions were found to be stable over the shelf life of the product. Other aspects of the invention relate to methods for making such compositions, as well as methods of using such compositions for perioperative care of a patient or for sedation.Type: ApplicationFiled: February 15, 2019Publication date: August 29, 2019Inventors: Ashish Anil Dubewar, Pradeep Kumar Kare, Kumar Swamy Ummiti, Ajay Kumar Singh